2017 Top 5 Postmenopausal Vaginal Atrophy Treatment Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

October 2017 | 112 pages | ID: 2331A1A7D33EN
LP Information

Abstracts

The Global Postmenopausal Vaginal Atrophy Treatment market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022.

This report studies the global Postmenopausal Vaginal Atrophy Treatment market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Postmenopausal Vaginal Atrophy Treatment players in each region, with sales, price, revenue and market share from 2012 to 2017, the top players including

• Pfizer
• Allergan
• Shionogi
• Novo Nordisk
• Teva Pharmaceutical
• Bayer.

Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2012 to 2017 (forecast), like

• North America (United States, Canada and Mexico)
• Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
• Europe (Germany, UK, France, Italy and Russia etc.
• South America (Brazil, Chile, Peru and Argentina)
• Middle East and Africa (Egypt, South Africa, Saudi Arabia)

Split by Product Types, with sales, revenue, price, market share of each type, can be divided into

• Creams
• Tablets
• Patches
• Rings

Split by applications, this report focuses on sales, market share and growth rate of Postmenopausal Vaginal Atrophy Treatment in each application, can be divided into

• Topical Estrogen
• Systemic Estrogen
• Non-hormonal Therapy

Contents

1 POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Postmenopausal Vaginal Atrophy Treatment
1.2 Postmenopausal Vaginal Atrophy Treatment Segment by Types
  1.2.1 Global Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016
  1.2.2 Creams
    1.2.2.1 Major Players of Creams
  1.2.3 Tablets
    1.2.3.1 Major Players of Tablets
  1.2.4 Patches
    1.2.4.1 Major Players of Patches
  1.2.5 Rings
    1.2.5.1 Major Players of Rings
1.3 Postmenopausal Vaginal Atrophy Treatment Segment by Applications
  1.3.1 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016
  1.3.2 Topical Estrogen
  1.3.3 Systemic Estrogen
  1.3.4 Non-hormonal Therapy
1.4 Postmenopausal Vaginal Atrophy Treatment Market by Regions
  1.4.1 North America Status and Prospect (2012-2022)
    1.4.1.1 North America Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
  1.4.2 Asia-Pacific Status and Prospect (2012-2022)
    1.4.2.1 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
    1.4.3.1 Europe Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
  1.4.4 South America Status and Prospect (2012-2022)
    1.4.4.1 South America Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
  1.4.5 Middle East and Africa Status and Prospect (2012-2022)
    1.4.5.1 Middle East and Africa Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
1.5 Global Market Size (Value) of Postmenopausal Vaginal Atrophy Treatment (2012-2022)

2 GLOBAL POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 Global Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Players in 2016 and 2017
  2.1.1 Global Postmenopausal Vaginal Atrophy Treatment Sales by Players in 2016 and 2017
  2.1.2 Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) by Players in 2016 and 2017
2.2 Global Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Players in 2016 and 2017
  2.2.1 Global Postmenopausal Vaginal Atrophy Treatment Revenue by Players in 2016 and 2017
  2.2.2 Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) by Players in 2016 and 2017
2.3 Global Postmenopausal Vaginal Atrophy Treatment Average Price by Players in 2016 and 2017
2.4 Global Postmenopausal Vaginal Atrophy Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
  2.4.1 Global Postmenopausal Vaginal Atrophy Treatment Manufacturing Base Distribution and Sales Area by Players
  2.4.2 Players Postmenopausal Vaginal Atrophy Treatment Product Types
2.5 Postmenopausal Vaginal Atrophy Treatment Market Competitive Situation and Trends
  2.5.1 Postmenopausal Vaginal Atrophy Treatment Market Concentration Rate
  2.5.2 Postmenopausal Vaginal Atrophy Treatment Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE (VALUE) BY REGIONS, TYPE AND APPLICATION (2012-2017)

3.1 Global Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Regions (2012-2017)
  3.1.1 Global Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Regions (2012-2017)
  3.1.2 Global Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Regions (2012-2017)
3.2 Global Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.2.1 Global Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
  3.2.2 Global Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
  3.2.3 Global Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
3.3 Global Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
  3.3.1 Global Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
  3.3.2 Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
3.4 Global Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

4 NORTH AMERICA TOP 5 PLAYERS POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE AND PRICE

4.1 North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share in 2016 and 2017
  4.1.1 North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales and Market Share in 2016 and 2017
  4.1.2 North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share in 2016 and 2017
4.2 North America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  4.2.1 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
    4.2.1.1 North America Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
    4.2.1.2 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
  4.2.2 North America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
    4.2.2.1 North America Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
    4.2.2.2 North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
  4.2.3 North America Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
4.3 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
  4.3.1 North America Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
  4.3.2 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
4.4 North America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Country (US, Canada and Mexico) (2012-2017)
  4.4.1 North America Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
  4.4.2 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
4.5 North America Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)

5 EUROPE TOP 5 PLAYERS POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE AND PRICE

5.1 Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share in 2016 and 2017
  5.1.1 Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales and Market Share in 2016 and 2017
  5.1.2 Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share in 2016 and 2017
5.2 Europe Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  5.2.1 Europe Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
    5.2.1.1 Europe Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
    5.2.1.2 Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
  5.2.2 Europe Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
    5.2.2.1 Europe Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
    5.2.2.2 Europe Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
  5.2.3 Europe Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
5.3 Europe Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
  5.3.1 Europe Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
  5.3.2 Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
5.4 Europe Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Country (Germany, UK, France, Italy and Russia) (2012-2017)
  5.4.1 Europe Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
  5.4.2 Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
5.5 Europe Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)

6 ASIA-PACIFIC TOP 5 PLAYERS POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE AND PRICE

6.1 Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share in 2016 and 2017
  6.1.1 Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales and Market Share in 2016 and 2017
  6.1.2 Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share in 2016 and 2017
6.2 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  6.2.1 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
    6.2.1.1 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
  6.2.2 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
  6.2.3 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
6.3 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
  6.3.1 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
  6.3.2 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
6.4 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Country (China, Japan, Southeast Asia, India and Korea) (2012-2017)
  6.4.1 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
  6.4.2 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
6.5 Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)

7 SOUTH AMERICA TOP 5 PLAYERS POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE AND PRICE

7.1 South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share in 2016 and 2017
  7.1.1 South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales and Market Share in 2016 and 2017
  7.1.2 South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share in 2016 and 2017
7.2 South America Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  7.2.1 South America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
    7.2.1.1 South America Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
    7.2.1.2 South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
  7.2.2 South America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
    7.2.2.1 South America Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
    7.2.2.2 South America Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
  7.2.3 South America Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
7.3 South America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
  7.3.1 South America Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
  7.3.2 South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
7.4 South America Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Country (Brazil, Argentina, Chile and Peru) (2012-2017)
  7.4.1 South America Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
  7.4.2 South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
7.5 South America Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)

8 MIDDLE EAST & AFRICA TOP 5 PLAYERS POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE AND PRICE

8.1 Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share in 2016 and 2017
  8.1.1 Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales and Market Share in 2016 and 2017
  8.1.2 Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share in 2016 and 2017
8.2 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  8.2.1 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
    8.2.1.1 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
    8.2.1.2 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
  8.2.2 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
    8.2.2.1 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
    8.2.2.2 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
  8.2.3 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
8.3 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
  8.3.1 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
  8.3.2 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
8.4 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Country (Egypt, Saudi Arabia, South Africa and Iran) (2012-2017)
  8.4.1 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
  8.4.2 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
8.5 Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)

9 GLOBAL POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT PLAYERS PROFILES/ANALYSIS

9.1 Pfizer
  9.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  9.1.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    9.1.2.1 Type
    9.1.2.2 Type
  9.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
  9.1.5 Pfizer News
9.2 Allergan
  9.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  9.2.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    9.2.2.1 Type
    9.2.2.2 Type
  9.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
  9.2.5 Allergan News
9.3 Shionogi
  9.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  9.3.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    9.3.2.1 Type
    9.3.2.2 Type
  9.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
  9.3.5 Shionogi News
9.4 Novo Nordisk
  9.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  9.4.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    9.4.2.1 Type
    9.4.2.2 Type
  9.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
  9.4.5 Novo Nordisk News
9.5 Teva Pharmaceutical
  9.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  9.5.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    9.5.2.1 Type
    9.5.2.2 Type
  9.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
  9.5.5 Teva Pharmaceutical News
9.6 Bayer.
  9.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  9.6.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    9.6.2.1 Type
    9.6.2.2 Type
  9.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
  9.6.5 Bayer. News

10 GLOBAL POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT MARKET FORECAST (2017-2022)

10.1 Global Postmenopausal Vaginal Atrophy Treatment Sales, Revenue Forecast (2017-2022)
10.2 Global Postmenopausal Vaginal Atrophy Treatment Sales, Consumption Forecast by Regions (2017-2022)
  10.2.1 Global Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Regions (2017-2022)
  10.2.2 Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Regions (2017-2022)
10.3 Global Postmenopausal Vaginal Atrophy Treatment Sales and Market Share Forecast by Type (2017-2022)
  10.3.1 Global Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)
  10.3.2 Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Type (2017-2022)
10.4 Global Postmenopausal Vaginal Atrophy Treatment Sales and Market Share Forecast by Application (2017-2022)
  10.4.1 Global Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)
  10.4.2 Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Application (2017-2022)
10.5 Postmenopausal Vaginal Atrophy Treatment Price Forecast (2017-2022)

11 POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT MANUFACTURING COST ANALYSIS

11.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Players in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Postmenopausal Vaginal Atrophy Treatment
Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment
Figure Global Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016
Figure Product Picture of Creams
Table Major Players of Creams
Figure Product Picture of Tablets
Table Major Players of Tablets
Figure Product Picture of Patches
Table Major Players of Patches
Figure Product Picture of Rings
Table Major Players of Rings
Figure Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016
Table Applications of Postmenopausal Vaginal Atrophy Treatment
Figure Topical Estrogen Examples
Figure Systemic Estrogen Examples
Figure Non-hormonal Therapy Examples
Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure South America Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East and Africa Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales by Players in 2016 and 2017
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) by Players in 2016 and 2017
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Players in 2016
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Players in 2017
Table Global Postmenopausal Vaginal Atrophy Treatment Revenue by Players in 2016 and 2017
Table Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) by Players in 2016 and 2017
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Players in 2016
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Players in 2017
Table Global Postmenopausal Vaginal Atrophy Treatment Average Price by Players in 2016 and 2017
Figure Global Postmenopausal Vaginal Atrophy Treatment Average Price by Players in 2016
Table Global Postmenopausal Vaginal Atrophy Treatment Manufacturing Base Distribution and Sales Area by Players
Table Players Postmenopausal Vaginal Atrophy Treatment Product Types
Figure Postmenopausal Vaginal Atrophy Treatment Market Share of Top 3 Players
Figure Postmenopausal Vaginal Atrophy Treatment Market Share of Top 5 Players
Table Global Postmenopausal Vaginal Atrophy Treatment Sales by Regions (2012-2017)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Regions (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Regions (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Regions in 2016
Table Global Postmenopausal Vaginal Atrophy Treatment Revenue by Regions (2012-2017)
Table Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Regions (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Regions (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Regions in 2016
Table Global Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type in 2016
Table Global Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Table Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type in 2016
Table Global Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application in 2016
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales in 2016 and 2017
Table North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) in 2016 and 2017
Figure North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2016
Figure North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2017
Table North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue in 2016 and 2017
Table North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) in 2016 and 2017
Figure North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2016
Figure North America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2017
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Figure 2016 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type in 2016
Table North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales by Application in 2016
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
Figure 2016 North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country
Table North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Figure North America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Table North America Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)
Table Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales in 2016 and 2017
Table Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) in 2016 and 2017
Figure Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2016
Figure Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2017
Table Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue in 2016 and 2017
Table Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) in 2016 and 2017
Figure Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2016
Figure Europe Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2017
Table Europe Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Figure 2016 Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type
Table Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Europe Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type in 2016
Table Europe Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Table Europe Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table Europe Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application in 2016
Table Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table Europe Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country in 2016
Table Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Figure Europe Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Table Europe Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)
Table Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales in 2016 and 2017
Table Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) in 2016 and 2017
Figure Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2016
Figure Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2017
Table Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue in 2016 and 2017
Table Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) in 2016 and 2017
Figure Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2016
Figure Asia-Pacific Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2017
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type in 2016
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type in 2016
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Application in 2016
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country in 2016
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Figure Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Table Asia-Pacific Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)
Table South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales in 2016 and 2017
Table South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) in 2016 and 2017
Figure South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2016
Figure South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2017
Table South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue in 2016 and 2017
Table South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) in 2016 and 2017
Figure South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2016
Figure South America Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2017
Table South America Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Sales by Type in 2016
Table South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table South America Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Revenue by Type in 2016
Table South America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Table South America Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table South America Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Sales by Application in 2016
Table South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table South America Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Sales by Country in 2016
Table South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Figure South America Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Table South America Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)
Table Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales in 2016 and 2017
Table Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) in 2016 and 2017
Figure Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2016
Figure Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Sales Share in 2017
Table Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue in 2016 and 2017
Table Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) in 2016 and 2017
Figure Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2016
Figure Middle East & Africa Top 5 Players Postmenopausal Vaginal Atrophy Treatment Revenue Share in 2017
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Type in 2016
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue by Type in 2016
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Application in 2016
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Country (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales by Country in 2016
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Figure Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Country (2012-2017)
Table Middle East & Africa Postmenopausal Vaginal Atrophy Treatment Import & Export (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Shionogi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Shionogi Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Bayer. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer. Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Figure Global Postmenopausal Vaginal Atrophy Treatment Sales and Growth Rate Forecast (2017-2022)
Figure Global Postmenopausal Vaginal Atrophy Treatment Revenue and Growth Rate Forecast (2017-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Regions (2017-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Regions (2017-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Type (2017-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)
Table Global Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Treatment
Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment
Figure Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis
Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Players in 2016
Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment
Table Distributors/Traders List